Zhongchao Inc. Launches MDT Hematology Training Platform to Improve Diagnosis and Treatment
SHANGHAI, September 17, 2021 / PRNewswire / – Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), an internet technology company providing healthcare professionals with the online platform for healthcare information, professional training and educational services and patient management platform, today announced the launch of its multidisciplinary therapy (“MDD”) clinical thinking training platform for hematology (” MDT hematology platform ”). The MDT Hematology Platform provides clinicians with a channel to acquire multidisciplinary thinking skills online, to improve diagnosis and treatment, and to enhance treatment effectiveness. MDT is a model of medical service in which multidisciplinary specialists discuss cases of a certain disease or systemic disease and then develop an optimal treatment plan for the patient taking into account the opinions of all disciplines. Experienced physicians are essential and necessary to organize and implement the PCT model, as the model requires standardized multidisciplinary collaboration with high-level patient participation.
MDT Hematology Platform is an online learning platform for primary care physicians, adopting real-time web communication or WebRTC technology where there is MDT theory module, exercise module practices, an expert orientation module and an interactive discussion module on core issues. Physicians can connect to Zhongchao’s MDMOOC platform to submit cases and issues encountered during patient consultation and treatment and seek solutions from multidisciplinary experts in real time. Additionally, physicians can watch MDT training videos to learn expert clinical thinking skills and improve their problem-solving ability during disease diagnosis and treatment.
The MDT Hematology Platform has brought together many authoritative experts in several disciplines related to hematology, including frontline experts and clinicians in hematology, infectious diseases, microbiology, immunology, blood transplantation from the Association. Chinese Medical Association, Chinese Physicians Association, ECCMID, Peking University. People’s Hospital, the first affiliated hospital of GUANGZHOU Medical University, Hospital 301, Fudan Zhongshan University Hospital, Shanghai Tongji Hospital, Ruijin Hospital, Army Medical University Affiliated Hospital, No.1 Affiliated Hospital of Medical University of Chongqing, Hainan General Hospital, Shenzhen People’s Hospital, First Affiliated Hospital of Zhejiang University Faculty of Medicine and Second Affiliate Hospital of Zhejiang University College of Medicine. From August 2021, more than 10,000 doctors connected to the MDT Hematology platform to participate in the learning and discussion.
In United States, MDT has been widely used to diagnose and treat complex diseases such as cancer, cardiovascular disease, and neurological disease, with over 90% of large hospitals using the MDT model. According to the list of the first batch of pilot hospitals for the diagnosis and multidisciplinary treatment of tumors (digestive system) announced by the National Health Care Commission on November 30, 2018, there were 231 Class A tertiary hospitals implementing MDT in China, representing 16% of class A tertiary hospitals and 9% of tertiary hospitals. As a result, the management of the Company believes that there is a huge demand for the application and popularization of the MDT model in China. Zhongchao’s MDT Hematology Platform provides physicians with convenient and rapid access to learn and exchange MDT practices and experiences and will promote the development of hematology treatment models in China. For the future, Zhongchao hopes to apply its MDT model to other areas of treatment, promote the extension and development of MDT in China, and improve the efficiency and quality of medical treatments.
About Zhongchao Inc.
Incorporated in 2012 with the head office at Shanghai and Beijing, China, Zhongchao Inc. is a platform-based internet technology company. It provides online health information, professional training and educational services to healthcare professionals under its “MDMOOC” platform (www.mdmooc.org) and to the public under its “Sunshine Health Forums” platform (www.ygjkclass. com) in China. Through its subsidiaries, the Company also operates a platform offering patient management services. Further information on the Company is available on its investor relations website at http://izcmd.com.
Safe Harbor Declaration
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding future plans, objectives, goals, strategies, events or performance, and assumptions underlying statements and other statements that are other than statements of historical fact. When the Company uses words such as “may”, “will”, “intention”, “should”, “believe”, “expect”, “anticipate”, “plan”, “estimate” or Similar phrases that do not relate only to matters, it makes forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties which may cause actual results to differ materially from the expectations of the Company discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to the following: the objectives and strategies of the Company; the future business development of the Company; demand and acceptance of products and services; technological changes; economic conditions; the growth of the vocational training and educational services market in China and other international markets that the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and the international markets that the Company expects to serve and the assumptions underlying or related to any of the aforementioned and other risks contained in the reports filed by the Company with the SEC, the duration and severity of the recent coronavirus outbreak , including its impacts on all of our activities and operations. For these and other reasons, investors are cautioned not to place undue reliance on any forward-looking statements contained in this press release. Additional factors are discussed in the Company’s filings with the SEC, which can be viewed at www.sec.gov. The Company assumes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
For more information please contact:
In the business: Pei Xu, CFO
Email: [email protected]
Phone: +86 21-3220-5987
Investor Relations: Sherry Zheng
Weitian Group SARL
Email: [email protected]
Telephone: +1 718-213-7386
SOURCE Zhongchao Inc.